HR 2666
Medicaid VBPs for Patients Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Medicaid VBPs for Patients Act (MVP Act), aims to modernize Medicaid drug pricing by allowing states to use ‘varying best price points’ in value-based purchasing arrangements. It requires the Centers for Medicare & Medicaid Services to establish a program for states to cover drugs in inpatient settings through these arrangements and mandates quarterly price reporting from manufacturers. The bill also modifies how average manufacturer prices are calculated and includes a GAO study to assess the impact of these arrangements on healthcare programs and patient access to innovative treatments.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
A. Drew, IV Ferguson
Anna G. Eshoo
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.